Skip to main content
OpenTrials

Clinical trial condition

Metastatic Malignant Neoplasm in the Bone

Explore clinical trials studying Metastatic Malignant Neoplasm in the Bone. Study availability and eligibility vary by location and protocol.

25 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Malignant Neoplasm in the Bone trial results

Recruiting

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

NCT04489719

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Bozeman Health Deaconess Hospital Bozeman, Montana, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Wisconsin-Madison Madison, Wisconsin, United States
View Trial Details
Recruiting

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

NCT03858205

Conditions
Blood Protein Disorders, Bone Pain, Cardiovascular Diseases, +15 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View Trial Details
Active, not recruiting

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

NCT06745024

Conditions
Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Banner-University Medical Center Phoenix Phoenix, Arizona, United States
View all 626 locations
View Trial Details
Active, not recruiting

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

NCT03793166

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 859 locations
View Trial Details
Active, not recruiting

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

NCT04071223

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Rush MD Anderson Cancer Center Chicago, Illinois, United States
View all 47 locations
View Trial Details

Related conditions